Chemoattractants produced by cancers also activate GPCRs and RTKs involved in PI3K phosphorylation and activation, like PI3K-δ in immature and immunosuppressive myeloid cells, further driving and sustaining tumor inflammation (114). This evidence concerns the gene PIK3CA and cancer.